These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6348657)

  • 21. Disc sensitivity of gonococci to rosoxacin, tetracycline and beta-lactam antibiotics.
    Mason PR; Latif AS; Gundiza MG
    Cent Afr J Med; 1983 Nov; 29(11):216-7. PubMed ID: 6423286
    [No Abstract]   [Full Text] [Related]  

  • 22. In-vitro antigonococcal activity of rosoxacin (WIN 35213).
    Warren CA; Shannon KP; Phillips I
    Br J Vener Dis; 1981 Feb; 57(1):33-5. PubMed ID: 6781706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro antibacterial activity of E-3604, a new 6-fluoroquinolone, on clinical isolates.
    Xicota MA; Coll R; Esteve M; Moros M; Parés J
    Drugs Exp Clin Res; 1987; 13(3):133-6. PubMed ID: 3622242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antibiotic sensitivity of bacteria isolated from patients at 6 hospitals in Osaka].
    Yama H; Murata Y; Yamanaka K; Ogawa Y; Miura H; Inoue S; Fujita I; Matsuno K; Nishino T
    Jpn J Antibiot; 1991 Sep; 44(9):926-40. PubMed ID: 1960855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In-vitro activity of cefonicid on hospital bacteria. Regression line and proposal for critical values].
    Chanal M; Cluzel M; Sirot D; Joly B; Sirot J; Cluzel R
    Pathol Biol (Paris); 1986 May; 34(5):385-9. PubMed ID: 3095773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro antimicrobial activity of rosoxacin against Neisseria gonorrhoeae, Chlamydia trachomatis, and Ureaplasma urealyticum.
    Dobson RA; O'Connor JR; Poulin SA; Kundsin RB; Smith TF; Came PE
    Antimicrob Agents Chemother; 1980 Nov; 18(5):738-40. PubMed ID: 6778385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro activity of ceftriaxone on hospital bacteria. Results of a multicenter study].
    Soussy CJ; Deforges L; Le Van Thoi J; Chanal M; Sirot D; Acar JF; Kitzis MD; Thabaut A; Meyran M; Dabernat H
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):469-72. PubMed ID: 2868442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory and bactericidal activities of amifloxacin, a new quinolone carboxylic acid, compared with those of seven other antimicrobial agents.
    Baltch AL; Sutphen NT; Smith RP; Conley PE
    Clin Ther; 1984; 7(1):73-80. PubMed ID: 6440708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multicenter study of the activity of pefloxacin on bacteria isolated in a hospital milieu].
    Soussy CJ; Acar JF; Bergogne-Berezin E; Christol D; Courtieu AL; Duval J; Fleurette J; Lareng MB; Morel C; Thabaut A
    Rev Med Interne; 1986 Mar; 7(2):197-204. PubMed ID: 3459222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acrosoxacin (rosoxacin) sensitivity of Neisseria strains].
    Fuzi M
    Orv Hetil; 1984 Apr; 125(17):1005-7. PubMed ID: 6425763
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative in vitro activity of Mk-0366 and other selected oral antimicrobial agents against Neisseria gonorrhoeae.
    Khan MY; Siddiqui Y; Gruninger RP
    Antimicrob Agents Chemother; 1981 Aug; 20(2):265-6. PubMed ID: 6456692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between antibacterial agents of the quinolone group and nitrofurantoin.
    Shah S; Greenwood D
    J Antimicrob Chemother; 1988 Jan; 21(1):41-8. PubMed ID: 3356622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rosoxacin in the therapy of uncomplicated gonorrhea.
    Romanowski B; Austin TW; Pattison FL; Lawee D; Portnoy D; Givan KF; Li EL; Nguyen KB
    Antimicrob Agents Chemother; 1984 Apr; 25(4):455-7. PubMed ID: 6428307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rosoxacin (Win 35,213) in the treatment of uncomplicated acute gonococcal infection.
    Woscoff A; Flichman JC; Man F; Martinez TE; de Martinez LR; Chouela E; Blanzaco DP
    Clin Ther; 1982; 4(6):515-25. PubMed ID: 7093983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance to quinolones.
    Mouton RP
    Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S11-5. PubMed ID: 3125517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraocular penetration of rosoxacin in rabbits.
    Hulem CD; Old SE; Zeleznick LD; Leopold IH
    Arch Ophthalmol; 1982 Apr; 100(4):646-9. PubMed ID: 7073586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of gonococcal W serogrouping in the evaluation of a clinical trial of rosoxacin.
    Rudén AK; Werner YK; Ringertz O; Bygdeman SM; Bäckman M; Sandström EG
    Sex Transm Dis; 1985; 12(1):19-24. PubMed ID: 3890225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-performance liquid chromatographic analysis of rosoxacin and its N-oxide metabolite in plasma and urine.
    Kullberg MP; Koss R; O'Neil S; Edelson J
    J Chromatogr; 1979 May; 173(1):155-63. PubMed ID: 546869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical evaluation of rosoxacin for the treatment of chancroid.
    Haase DA; Ndinya-Achola JO; Nash RA; D'Costa LJ; Hazlett D; Lubwama S; Nsanze H; Ronald AR
    Antimicrob Agents Chemother; 1986 Jul; 30(1):39-41. PubMed ID: 3489439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human prostatic tissue concentrations of rosoxacin.
    Jensen KM; Patel RB; Welling PG; Madsen PO
    Prostate; 1982; 3(5):523-9. PubMed ID: 7145776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.